RxDoctor Payments Data

Mallory Emig, MD

Neurology · Helena, MTNPI 1831696236

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $221, 2.5 times the $87 reported in 2019. That places this record below the midpoint for neurology clinicians in MT, where the typical reported total is $1,082.

$876in general payments, 2019–2025

Across 17 payments — averaging $51.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • EMD Serono, Inc.$131
  • AstraZeneca$123
  • TG Therapeutics, Inc.$112
  • UCB, Inc.$88
  • Akcea Therapeutics, Inc.$87
  • Eisai Inc.$87
  • plus $248 from 7 others

What the payments were for

  • Food & beverage$876100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$876 in reported general payments places this provider in the 45th percentile of 48 neurology providers in Montana.

See all neurology providers in Montana

Medicare billing

Part B allowed, 2024
$46,605
Medicare patients
227
Services billed
500

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EpidiolexCannabidiol (Cbd)20$135,623
Aimovig AutoinjectorErenumab-Aooe20$18,677
ReyvowLasmiditan Succinate16$12,675
Lamotrigine ErLamotrigine39$4,426
Levetiracetam117$2,700
Divalproex Sodium ErDivalproex Sodium56$2,199
Lacosamide17$1,487
Carbamazepine12$1,306
Carbidopa-LevodopaCarbidopa/Levodopa65$1,076
Oxcarbazepine36$799
Lamotrigine53$791
Memantine Hcl69$711
Teriflunomide11$497
Carbidopa-Levodopa ErCarbidopa/Levodopa11$473
Prednisone16$375

Paid to pharmacies, not to this prescriber.

Other neurology in Helena

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →